These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25063756)

  • 1. Prolactin receptor antagonism uncouples lipids from atherosclerosis susceptibility.
    van der Sluis RJ; van den Aardweg T; Reuwer AQ; Twickler MT; Boutillon F; Van Eck M; Goffin V; Hoekstra M
    J Endocrinol; 2014 Sep; 222(3):341-50. PubMed ID: 25063756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.
    Jomain JB; Tallet E; Broutin I; Hoos S; van Agthoven J; Ducruix A; Kelly PA; Kragelund BB; England P; Goffin V
    J Biol Chem; 2007 Nov; 282(45):33118-31. PubMed ID: 17785459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression.
    Ferraris J; Boutillon F; Bernadet M; Seilicovich A; Goffin V; Pisera D
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E356-64. PubMed ID: 22094470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-induced (epigenetic) changes in bone marrow augment atherosclerosis.
    van Kampen E; Jaminon A; van Berkel TJ; Van Eck M
    J Leukoc Biol; 2014 Nov; 96(5):833-41. PubMed ID: 25024399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenalectomy stimulates the formation of initial atherosclerotic lesions: reversal by adrenal transplantation.
    van der Sluis RJ; van Puijvelde GH; Van Berkel TJ; Hoekstra M
    Atherosclerosis; 2012 Mar; 221(1):76-83. PubMed ID: 22236481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.
    Peirce SK; Chen WY
    Oncogene; 2004 Feb; 23(6):1248-55. PubMed ID: 14647416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
    Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
    Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
    Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.
    Tomblyn S; Langenheim JF; Jacquemart IC; Holle E; Chen WY
    Int J Oncol; 2005 Nov; 27(5):1381-9. PubMed ID: 16211235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice.
    Hasu M; Thabet M; Tam N; Whitman SC
    Can J Physiol Pharmacol; 2011 Oct; 89(10):737-42. PubMed ID: 21895526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prolactin receptor antagonist to better understand prolactin regulation of pituitary homeostasis.
    Ferraris J; Bernichtein S; Pisera D; Goffin V
    Neuroendocrinology; 2013; 98(3):171-9. PubMed ID: 23969780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
    Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
    J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke.
    Han SG; Howatt DA; Daugherty A; Gairola CG
    Toxicology; 2012 Sep; 299(2-3):133-8. PubMed ID: 22659316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
    van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
    PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.